Vitamin C promotes maturation of T-cells.
Level 5 - mechanism / opinion, no new human data
Preclinical bench and animal research without human subjects
PubMed 23249337 · doi:10.1089/ars.2012.4988
What was done
Researchers evaluated the role of ascorbic acid in lymphocyte development using an in vitro model of mouse bone marrow-derived progenitor cells differentiating into T-lymphocytes, alongside in vivo mouse assessments. They evaluated T-cell receptor rearrangements, CD8 and ZAP70 gene expression, and the effects of pharmacologic inhibition of DNA and histone methylation.
What was found
No quantitative values or statistical metrics are reported in the abstract. Ascorbic acid was found to be essential for the in vitro progression of mouse progenitor cells to functional T-lymphocytes and had an in vivo role. The effect was intrinsic to lymphoid cells, independent of T-cell receptor rearrangement, and enhanced functional TCRαβ selection after β-selection. Ascorbic acid upregulated CD8 and ZAP70, and pharmacologic inhibition of DNA and histone methylation enhanced differentiation, pointing to active demethylation by ascorbate-dependent dioxygenases.
Why it matters
This study outlines a specific epigenetic mechanism by which vitamin C acts as a cofactor for dioxygenases to drive lymphocyte development.
Limits
The study is restricted to in vitro mouse cells and animal models, so findings cannot be directly applied to human immune function or clinical nutrition. The abstract does not disclose sample sizes, exact concentrations, or quantitative effect sizes.
Cited by
- supports Multiple in vitro studies in mouse and human cell lines have demonstrated that culturing T cells with vitamin C can enhance T cell development.